E J Feldman - JoVE Visualize

Showing results (21-30 of 45) with videos related to

Pageof 5

Sort By:

Leukemia & Lymphoma|November 8, 2001

Intravenous bolus topotecan in patients with myelodysplastic syndromeK Seiter, D Liu, E J Feldman, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1992

Phenotypic analysis of 1-B-D-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with responseW Kreis, M Lesser, D R Budman, et al.

Cancer|December 11, 1999

A phase I-II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemiaC A Koller, H M Kantarjian, E J Feldman, et al.

Hematology (Amsterdam, Netherlands)|June 16, 2001

Malignancy: A New Approach to the Analysis of Apoptosis in the Leukemic Subpopulation by Flow Cytometry Using a CD45 Gating StrategyA. Deptala, H. D. Halicka, T. Salomon, et al.

Leukemia & Lymphoma|June 1, 2000

Phase II evaluation of a high-dose mitoxantrone based induction regimen in untreated adults with acute myeloid leukemiaE J Feldman, K Seiter, F Traganos, et al.

Leukemia|April 1, 1997

A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemiaE J Feldman, K Seiter, L Damon, et al.

Acta Haematologica|January 1, 1989

Acute promyelocytic leukemia: a 5-year experience with new antileukemic agents and a new approach to preventing fatal hemorrhageE J Feldman, Z A Arlin, T Ahmed, et al.

Acta Haematologica|January 1, 1994

Incidence and treatment of tumor lysis syndrome in patients with acute leukemiaE Razis, Z A Arlin, T Ahmed, et al.

Journal of Medicine|January 1, 1994

TMJ: a well-tolerated high-dose regimen for the adjuvant chemotherapy of high risk breast cancerE D Razis, G Samonis, P Cook, et al.

Leukemia|June 22, 2001

Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapyK Seiter, E J Feldman, C Sreekantaiah, et al.

Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:

Pageof 5

Leukemia & Lymphoma|November 8, 2001

Intravenous bolus topotecan in patients with myelodysplastic syndromeK Seiter, D Liu, E J Feldman, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1992

Phenotypic analysis of 1-B-D-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with responseW Kreis, M Lesser, D R Budman, et al.

Cancer|December 11, 1999

A phase I-II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemiaC A Koller, H M Kantarjian, E J Feldman, et al.

Hematology (Amsterdam, Netherlands)|June 16, 2001

Malignancy: A New Approach to the Analysis of Apoptosis in the Leukemic Subpopulation by Flow Cytometry Using a CD45 Gating StrategyA. Deptala, H. D. Halicka, T. Salomon, et al.

Leukemia & Lymphoma|June 1, 2000

Phase II evaluation of a high-dose mitoxantrone based induction regimen in untreated adults with acute myeloid leukemiaE J Feldman, K Seiter, F Traganos, et al.

Leukemia|April 1, 1997

A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemiaE J Feldman, K Seiter, L Damon, et al.

Acta Haematologica|January 1, 1989

Acute promyelocytic leukemia: a 5-year experience with new antileukemic agents and a new approach to preventing fatal hemorrhageE J Feldman, Z A Arlin, T Ahmed, et al.

Acta Haematologica|January 1, 1994

Incidence and treatment of tumor lysis syndrome in patients with acute leukemiaE Razis, Z A Arlin, T Ahmed, et al.

Journal of Medicine|January 1, 1994

TMJ: a well-tolerated high-dose regimen for the adjuvant chemotherapy of high risk breast cancerE D Razis, G Samonis, P Cook, et al.

Leukemia|June 22, 2001

Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapyK Seiter, E J Feldman, C Sreekantaiah, et al.

Pageof 5